INGN 241
AXP000153.1 · Viral vector gene therapy
- Platform
- adenovirus (Ad5, non-replicating, mda-7/IL-24)
- Targets
- IL24
- Originator
- Introgen Therapeutics
- Sponsor
- Introgen Therapeutics
Names
| Name | Type | Source |
|---|---|---|
| INGN 241 | preferred name, code | curator, ncit |
| Ad-MDA-7 ambiguous | code | ncit |
| Adenovector Encoding MDA7 ambiguous | synonym | ncit |
Virus
- Role
- In vivo gene transfer
- Family
- Adenoviridae
- Virus
- human adenovirus 5 (NCBI Taxonomy 28285)
- Strain
- Ad5
- Replication
- non replicating
- Modifications
- non-replicating adenoviral vector encoding human IL-24 (mda-7)
- Transgenes
- IL24
- Route
- intratumoral
- Source
- evidence
Cross-references
- NCI Thesaurus
- C48368
Approvals
No regulatory approval recorded.
Clinical trials (1)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT00116363 | Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma | Unknown | Phase 2 | 2005-03 | 25 | Malignant Melanoma; Neoplasm Metastasis |
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 35149587 | Combined Inhibition of G9a and EZH2 Suppresses Tumor Growth via Synergistic Induction of IL24-Mediated Apoptosis. | Cancer research | 2022 | cited by trial NCT00116363 |
| PMID 15585416 | Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. | Molecular therapy : the journal of the American Society of Gene Therapy | 2005 | name in title: INGN 241 |
| PMID 15585417 | Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. | Molecular therapy : the journal of the American Society of Gene Therapy | 2005 | name in title: INGN 241 |
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 29551126 | Role of MDA-7/IL-24 a Multifunction Protein in Human Diseases. | Advances in cancer research | 2018 | name in abstract: INGN 241 |
| PMID 23481022 | Stabilization of MDA-7/IL-24 for colon cancer therapy. | Cancer letters | 2013 | name in abstract: INGN 241 |
| PMID 23661648 | Histone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cells. | Molecular pharmacology | 2013 | name in abstract: INGN 241 |
| PMID 20613485 | MDA-7/IL-24 as a cancer therapeutic: from bench to bedside. | Anti-cancer drugs | 2010 | name in abstract: INGN 241 |
| PMID 20732354 | The development of MDA-7/IL-24 as a cancer therapeutic. | Pharmacology & therapeutics | 2010 | name in abstract: INGN 241 |
| PMID 19276652 | Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24. | Cancer biology & therapy | 2009 | name in abstract: INGN 241 |
| PMID 18774929 | Ad-MDA-7; INGN 241: a review of preclinical and clinical experience. | Expert opinion on biological therapy | 2008 | name in title: INGN 241 |
| PMID 17208263 | Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma. | Toxicology and applied pharmacology | 2007 | name in abstract: INGN 241 |
| PMID 17477796 | Melanoma differentiation associated gene-7 (mda-7)/IL-24: a 'magic bullet' for cancer therapy? | Expert opinion on biological therapy | 2007 | name in abstract: INGN 241 |
| PMID 15880678 | MDA-7/IL-24 regulates proliferation, invasion and tumor cell radiosensitivity: a new cancer therapy? | Journal of cellular biochemistry | 2005 | name in abstract: INGN 241 |
| PMID 12690708 | Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology | 2003 | name in abstract: INGN 241 |
| PMID 12528316 | INGN-241. Introgen. | Current opinion in investigational drugs (London, England : 2000) | 2002 | name in title: INGN 241 |
Unconfirmed matches (5)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 20939432 | Ad.mda-7 (IL-24) selectively induces apoptosis in hepatocellular carcinoma cell lines, suppresses metastasis, and enhances the effect of doxorubicin on xenograft tumors. | Oncology research | 2010 | name in title: Ad-MDA-7 |
| PMID 18059175 | Development of Ad-mda7/IL-24-resistant lung cancer cell lines. | Cancer biology & therapy | 2008 | name in title: Ad-MDA-7 |
| PMID 16924242 | Targeting inhibition of K-ras enhances Ad.mda-7-induced growth suppression and apoptosis in mutant K-ras colorectal cancer cells. | Oncogene | 2007 | name in title: Ad-MDA-7 |
| PMID 17111370 | Combinatorial treatment of non-small-cell lung cancers with gefitinib and Ad.mda-7 enhances apoptosis-induction and reverses resistance to a single therapy. | Journal of cellular physiology | 2007 | name in title: Ad-MDA-7 |
| PMID 15580305 | Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis. | Oncogene | 2005 | name in title: Ad-MDA-7 |
NIH grants
| Project | Title | Organisation | PI | Years | Linked by |
|---|---|---|---|---|---|
| R03CA140024 | Ultrasound-guided gene delivery in pancreatic cancer | MARSHALL UNIVERSITY | CLAUDIO, PIER PAOLO | 2009–2010 | name in abstract: INGN 241 |
| P01CA104177 | Translational Applications of mda-7/IL-24 in Cancer | VIRGINIA COMMONWEALTH UNIVERSITY | FISHER, PAUL B | 2005–2009 | name in abstract: INGN 241 |
Notes
Ad-mda7: adenovirus carrying melanoma differentiation-associated gene 7 (IL-24), injected intratumorally in phase 1 trials in melanoma and other solid tumours. Development stopped with Introgen.
How to cite
INGN 241 (AXP000153.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000153.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.